![]() |
Trials |
KCP-330-005A Phase II, Open-label Study of Efficacy and Safety of the Selective Inhibitor of Nuclear Export/SINE™ Compound KPT-330 (Selinexor) in Patients with Advanced Gynaecologic MalignanciesCancer type: Ovarian cancer Phase: II Principal Investigator: Mau-Sørensen Morten Country: DK Keywords: Denmark, Rigshospitalet, SINE Status: Completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02025985?term=KCP-330-005&rank=1 |